Pregabalin Market Size, Share and Trends Analysis Report Forecast 2024-2031
Pregabalin Market Size, Share and Trends Analysis Report Forecast 2024-2031
Blog Article
The global pregabalin market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Pregabalin is a medication that is used to treat epilepsy and anxiety. It is also used to treat nerve pain that can be caused by different conditions including diabetes and shingles, or an injury. The major factor driving the demand for the global pregabalin market during the forecast period is the increasing prevalence of epilepsy across the globe. Moreover, the market is also growing due to the growing geriatric population coupled with the increasing prevalence of diabetes as well as neuropathic pain among people globally.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/pregabalin-market
According to the World Health Organization (WHO), in 2019, epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Additionally, almost 80% of people with epilepsy live in low and middle-income countries and up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. However, the risk of mortality is three times higher in people with epilepsy than in the general population. Hence the rising prevalence of epilepsy is driving the demand for pregabalin for treatment which in turn is boosting its market growth.
Some major players in the market include copyright Inc., Teva Pharmaceutical Industries Ltd., and Cipla Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, Sawai announced the launch of the first generic version of the Lyrica pregabalin brand in Japan.
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- copyright Inc., Teva Pharmaceutical Industries Ltd., and Cipla Ltd., among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Pregabalin Market Report by Segment
By Type
Capsules
Oral Solutions
Others
By Application
Epilepsy
Neuropathic Pain
Anxiety Disorder
Others
Inquire for Discount on this Report at
https://www.omrglobal.com/report-customization/pregabalin-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404